Yuka Kajiura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Impact of BRCA1/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgery.
Journal: Breast cancer research and treatment
Published: December 30, 2025
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.
Journal: Breast cancer (Tokyo, Japan)
Published: March 17, 2025
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.
Journal: Breast cancer (Tokyo, Japan)
Published: June 17, 2024
Breast cancer during pregnancy of Luminal A type overexpressed CXCL13.
Journal: Pathology international
Published: March 20, 2024
Correction: Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal: Journal of medical ultrasonics (2001)
Published: May 25, 2023
Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: September 28, 2022
Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers.
Journal: Journal of medical ultrasonics (2001)
Published: September 13, 2022
Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.
Journal: Annals of surgical oncology
Published: August 10, 2022
Relationship Between Breast Density, Breast Cancer Subtypes, and Prognosis.
Journal: Clinical breast cancer
Published: June 23, 2021
Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.
Journal: Clinical breast cancer
Published: October 29, 2020
Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER+ HER2- Breast Cancer: A Prospective Phase II Study.
Journal: Clinical breast cancer
Published: June 23, 2020
A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
Journal: Journal of surgical oncology
Published: September 25, 2013
Last Updated: 09/26/2026